By Market & Region

Hong Kong – – October 02, 2026 -- Ascletis Pharma Inc. (HKEX: 1672) presented preclinical data showing its ASC36_35FDC injectable combination drove a 24.8% body-weight reduction in a diet-induced obesity rat model on Day 14, outperforming two competitor co-formulations tested under identical dosing conditions.

The data were unveiled in a short oral discussion at the 62nd European Association for the Study of Diabetes (EASD) Annual Meeting, held September 28–October 2, 2026, in Milan, Italy.

Costa Mesa, Calif. – October 02, 2026 -- Nearly 40% of women with postpartum depression showed a hyperfrontal/anterior cingulate cortex brain-activity pattern, more than double the 19.4% rate found in patients with major depression, according to new research from Dr. Daniel Amen and colleagues at Amen Clinics.

Brain scan comparison covers 26,135 patients across two depression groups

Researchers analyzed brain SPECT imaging scans from 58 women diagnosed with postpartum depression (PPD) and compared them against scans from 26,077 people with major depression. Each scan was classified into one of six brain-function categories: hyperfrontal/ACC, limbic, hypofrontal, toxic/diffuse low perfusion, brain trauma/acquired injury, or mixed patterns.

Jeddah – October 02, 2026 -- The Mysk Al Wadi Jeddah Hotel, the first Mysk-branded luxury property in Saudi Arabia, will open in September 2026 after builders treated over 2,000 cubic meters of concrete with crystalline waterproofing admixture to counter high groundwater and chloride exposure at the Red Sea construction site.

General contractor specified PENETRON ADMIX for below-grade structures exposed to groundwater

Faraj Abdulkarim Est, the project's general contractor, required a waterproofing solution for below-grade concrete after excavation depths revealed elevated groundwater levels at the site in Jeddah's Obhur district, near the Jeddah Corniche. Sam Annous, Managing Director of Penetron Saudi Arabia, said the hotel's proximity to the Red Sea made resilience against chloride-rich conditions a parallel priority alongside groundwater control.

Stockholm – October 02, 2026 -- Skanska has signed an additional USD 60 million (SEK 560 million) contract with Lee Health for the construction of a new hospital and medical office building in Fort Myers, Florida. The sum will be booked in Skanska's US order intake for the third quarter of 2026.

Contract amendment covers interior and mechanical work for bed tower expansion

The amendment adds interior build-out finishes and mechanical, electrical and plumbing work tied to the project's West Bed Tower expansion. It builds on the original full project agreement between Skanska and Lee Health.

Full project scope totals roughly 50,200 square meters of hospital and medical office space

The complete contract scope includes a five-story hospital of approximately 38,600 square meters (416,000 square feet), a central energy plant, and an 11,600-square-meter (125,000-square-foot) medical office building that houses an ambulatory surgery center.

Los Angeles – October 02, 2026 -- FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) showcased the EAI Robotics business of Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) at IROS 2026 in Pittsburgh, Pennsylvania, held September 28-30, 2026, as the two companies advance a non-binding term sheet that values the robotics unit at approximately $200 million.

All-New Futurist robot draws most attendee interest at Pittsburgh conference

FF displayed multiple EAI robot products built on its "One-Brain Multi-Form Multi-Capability" EAI Robot World 2.0 architecture. The All-New Futurist unit attracted particular attention for its mobile operation and flexible task execution across demonstrated scenarios. The company also introduced its "Built in USA" Acceleration Program during the three-day event, one of the largest robotics research conferences globally.

Stockholm – October 02, 2026 -- Autoliv, Inc. (NYSE: ALV; SSE: ALIVsdb) has appointed Natalie Draisin and Thomas Manfred Müller to its Research Advisory Board, expanding a panel of external experts that guides the automotive safety supplier's long-term research agenda.

Autoliv broadens external expertise with public health and automotive industry veterans

Natalie Draisin serves as Director of the North American Office and United Nations Representative at FIA Foundation and is an External Affiliate at Johns Hopkins Bloomberg School of Public Health. Thomas Manfred Müller, PhD, is a board member, advisor and business angel with executive experience at Audi, BMW, Volvo Cars, and Volkswagen Group.

Valby – October 02, 2026 -- H. Lundbeck A/S will present late-breaking Phase III data on its multiple system atrophy (MSA) drug candidate amlenetug alongside new Parkinson's disease pipeline results at the International Congress of Parkinson's Disease and Movement Disorders (MDS) 2026 in Seoul, South Korea, running October 4-8.

MASCOT trial enrolled 401 participants across a global Phase III program

The late-breaking oral presentation will detail baseline characteristics of participants in MASCOT (NCT06706622), Lundbeck's ongoing Phase III trial of amlenetug in MSA. The trial enrolled 401 participants with clinically probable or established MSA, covering both MSA-C and MSA-P subtypes, across sites in North America, Europe, Asia and Australia. The double-blind treatment period runs 72 weeks, comparing high- and low-dose amlenetug against placebo, with results expected in Q3 2027.

Seoul – October 02, 2026 -- AUTOCRYPT has established a Public Key Infrastructure (PKI) system for Plug&Charge (PnC) services in South Korea, validated across electric vehicles from six global automotive brands.

Six automakers validate shared authentication framework

The PKI infrastructure was tested on vehicles from Hyundai Motor, Kia, KG Mobility, BMW, Mercedes-Benz and Tesla, enabling these brands to connect to charging point operators (CPOs) through a single authentication system rather than separate proprietary frameworks.

Stockholm – October 02, 2026 -- Skanska has signed a USD 271 million (approximately SEK 2.5 billion) contract with NAVFAC Mid-Atlantic to construct a new homeport pier at Naval Station Newport in Newport, Rhode Island. The deal will be booked in Skanska's U.S. order intake for the third quarter of 2026.

New Pier Replaces Aging Infrastructure at Active Navy Installation

The project calls for the demolition of the existing Pier 1, which measures approximately 30 meters by 482 meters (100 feet by 1,580 feet). In its place, Skanska will build a smaller, modern pier spanning roughly 24 meters by 305 meters (80 feet by 1,000 feet), engineered to berth four U.S. Coast Guard Offshore Patrol Cutters.

London – October 02, 2026 -- Samfara has completed the acquisition of Chr. Olesen Synthesis, a Danish manufacturer of controlled-substance active pharmaceutical ingredients, marking the London-based life sciences investment firm's first deal. The transaction sees Samfara buy the business from Chr. Olesen and funds managed by Signet Healthcare Partners, with Chief Executive Thomas Moestrup co-investing alongside the new owner. Financial terms were not disclosed.

Chr. Olesen Synthesis supplies opioid-disorder and ADHD treatment ingredients globally

Based near Copenhagen, Chr. Olesen Synthesis develops and manufactures APIs and advanced intermediates specialising in controlled substances, including buprenorphine for opioid use disorder and lisdexamfetamine for ADHD. Its cGMP-certified plant in Hvidovre has been in commercial production since 2015, supplying pharmaceutical companies across Europe, North America and the Middle East.

Singapore – October 02, 2026 -- AhaSlides has won the 2026 Training Magazine Network Choice Award in the Gamification & Game-Based Learning category, a prize decided entirely by votes from working L&D professionals rather than editorial judges.

Voting pool of 2,207 trainers cast 11,692 votes across 296 companies

The Choice Awards, run by Training Magazine Network's 100,000+ member base, collected ballots between April 28 and June 30, 2026, spanning seven categories. Training magazine Editor/Publisher Lorri Freifeld announced the results on September 29, 2026.

Suzhou – October 02, 2026 -- Novartis has agreed to pay Abogen Biosciences an upfront fee of USD 575 million to secure worldwide rights to ABO2203, an mRNA-encoded CD19xCD3 T-cell engager for autoimmune diseases, with total deal value reaching up to approximately USD 7.2 billion if all milestones and options are exercised.

Novartis secures exclusive worldwide license to Abogen's lead autoimmune asset ABO2203

The licensing and option agreement grants Novartis an exclusive global license to ABO2203, which Abogen describes as the first mRNA-encoded T-cell engager to enter clinical evaluation for autoimmune diseases. The molecule uses mRNA to direct endogenous production of T-cell engagers in vivo, targeting B-cell depletion through a mechanism the companies say differs from traditional recombinant T-cell engagers.

Beijing – October 02, 2026 -- iQIYI's AIGC film series "The Ferry Man" has generated cumulative revenue-sharing earnings exceeding RMB 8 million (US$1.2 million) as of September 23, validating artificial intelligence as a financially viable film production model. The milestone arrives as the third installment, "The Ferry Man: The Dream of the Princess", debuts October 1 on iQIYI and iQIYI International.

Production costs recovered within first week of release

The series, produced jointly by iQIYI and GHY Culture & Media, recovered its full production costs within seven days of launch and crossed the RMB 8 million revenue-sharing threshold within its first month, according to the company. The first two titles, "Butterfly Dream" and "The Dream of the Celestial Maiden", released simultaneously on August 22.

Milan – October 02, 2026 -- Hansoh Pharma's dual-biased GLP-1/GIP receptor agonist Olatorepatide (HS-20094) achieved a mean weight loss of 19.3% at Week 48 in the 15 mg dose group of a Phase III Chinese trial, with no plateau observed in the weight-loss curve.

The data, presented as a Late-breaking Abstract oral presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting running September 28 to October 2, 2026 in Milan, come from the LIGHTEN study, a multicenter, randomized, double-blind, placebo-controlled trial enrolling 604 Chinese adults with overweight or obesity.

Trial enrolled 604 participants across four dose arms over 48 weeks

Participants with a BMI of 28 kg/m2 or above, or 24-28 kg/m2 with a weight-related comorbidity, were randomized 1:1:1:1 to once-weekly subcutaneous Olatorepatide at 5mg, 10mg or 15mg, or placebo. A total of 90.1% completed the full 48-week treatment period.

San Francisco -- October 1, 2026 -- MontoHealth is developing an AI-driven action layer designed to execute routine healthcare tasks—not just discuss them—across existing hospital and clinic software systems.

MontoHealth targets the gap between digitized records and automated work

Despite two decades of healthcare digitization, tasks such as rescheduling an appointment, routing a prescription refill, coordinating a referral or resolving an insurance query still require manual phone calls and handoffs across disconnected systems. Healthcare organizations typically operate EHRs, scheduling platforms, billing systems and patient portals as separate applications, each governed by distinct privacy and security controls. MontoHealth argues that digitizing a workflow has not equated to automating it, leaving staff to perform the connective work between systems.

Miami – October 01, 2026 -- Nuix used Sibos 2026 to position its Nuix Neo platform as a tool for financial institutions to convert unstructured data into usable financial crime intelligence, citing that up to 90% of enterprise data remains unreadable by conventional systems.

Nuix Neo processes over 1,000 file types to surface hidden risk signals

The platform's patented processing engine extracts information from emails, chat logs, counterparty data, transaction records, case files and voice recordings at a binary level. Deterministic natural language processing classifies and risk-scores the data, while semantic search surfaces relevant documents across languages based on meaning rather than keywords alone.

"AI is only as good as the data beneath it, and in complex financial crime investigations seeing and connecting all evidence is critical," said Chris Stephenson, Head of Industry Advocacy at Nuix.

Los Angeles – October 01, 2026 -- Dunn-Edwards Corporation has designated French Press Coffee (DEBN07), a deep brown with a subtle plum undertone, as its 2027 Color of the Year, signaling a commercial shift away from the cool grays and flat beiges that dominated paint specifications in recent years.

Dunn-Edwards color experts identify a market pivot toward warm, earthy neutrals

The company's internal color team tracked a decisive move away from stark whites and charcoal tones, positioning French Press Coffee as a moody neutral alternative to black that is gaining traction in upscale residential and commercial interiors.

Chicago – October 01, 2026 -- Ballard Power Systems has launched Fleet360, a fuel cell lifecycle program that guarantees power output performance for up to 250,000 miles of operation, unveiled at APTA TRANSform & EXPO 2026 in Chicago.

Fleet360 ties a performance guarantee to data, parts and training for North American transit fleets

The program is available with new FCmove-HD+ module sales in North America and bundles fuel cell health data, technical support, parts assurance, technician training and refurbishment options into a single service structure. Its FCcare+ coverage package provides the headline 250,000-mile power output guarantee, while the base FCcare package covers full parts coverage with defined response, spare-part delivery and resolution commitments.

Toronto – October 01, 2026 -- Manulife Financial Corporation has closed a reinsurance transaction transferring biometric risk on a block of long-term care policies carrying $3.2 billion in reserves to Munich American Reassurance Company, a US subsidiary of Munich Re Group.

Manulife offloads $3.2 billion in long-term care reserves to Munich Re Life US

The deal shifts biometric risk exposure tied to the long-term care block off Manulife's balance sheet and onto Munich Re Life US, a subsidiary specializing in life and disability reinsurance for North American carriers. The transaction was first announced on August 5, 2026, and has now reached formal closing.

San Clemente, Calif. – October 01, 2026 -- Angelalign Technology Inc. (6699.HK) has launched Pressure Points in the European market, a feature that replaces its existing Torque Ridges and delivers a 25% increase in tooth surface contact in its single pressure point configuration.

Angelalign replaces hand-made dimples with a digitally scalable force-control feature

Pressure Points is engineered to apply force at or near the center of the contact point, a departure from the hand-made dimples orthodontists have long used to correct torque and rotation. The company states the simplified dimple shape improves predictability of force application compared with current methods.